Outstanding Questions in the Clinical Management of Triple-Negative Breast Cancer
J Oncol Pract
.
2017 May;13(5):305-307.
doi: 10.1200/JOP.2017.023341.
Authors
Joshua J Gruber
1
,
Melinda L Telli
1
Affiliation
1
Stanford University School of Medicine, Stanford, CA.
PMID:
28489983
DOI:
10.1200/JOP.2017.023341
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms
Humans
Receptor, ErbB-2*
Receptors, Estrogen
Triple Negative Breast Neoplasms*
Substances
Receptors, Estrogen
Receptor, ErbB-2